Pasithea Therapeutics drops 19% on $5M private placement

seekingalpha09-27

Clinical-stage biotechnology company Pasithea Therapeutics (NASDAQ:KTTA) entered into definitive agreements for the issuance and sale of an aggregate of ~1.22M shares and warrants at a purchase price ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470677260?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-27 15:50","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2470677260","market":"sg","top_or_hot":-1,"title":"Pasithea Therapeutics drops 19% on $5M private placement","media":"seekingalpha","content":"<div>\n<p>Clinical-stage biotechnology company Pasithea Therapeutics (NASDAQ:KTTA) entered into definitive agreements for the issuance and sale of an aggregate of ~1.22M shares and warrants at a purchase price ...</p>\n\n<a href=\"https://seekingalpha.com/news/4153981-pasithea-therapeutics-drops-19-on-5m-private-placement\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pasithea Therapeutics drops 19% on $5M private placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPasithea Therapeutics drops 19% on $5M private placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-27 15:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4153981-pasithea-therapeutics-drops-19-on-5m-private-placement><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clinical-stage biotechnology company Pasithea Therapeutics (NASDAQ:KTTA) entered into definitive agreements for the issuance and sale of an aggregate of ~1.22M shares and warrants at a purchase price ...</p>\n\n<a href=\"https://seekingalpha.com/news/4153981-pasithea-therapeutics-drops-19-on-5m-private-placement\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KTTA","symbol_name":"Pasithea Therapeutics Corp.","start_time":0,"source_url":"https://seekingalpha.com/news/4153981-pasithea-therapeutics-drops-19-on-5m-private-placement","article_id":"2470677260","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470677260","pubTimestamp":1727423430,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Clinical-stage biotechnology company Pasithea Therapeutics  entered into definitive agreements for the issuance and sale of an aggregate of ~1.22M shares and warrants at a purchase price of $4.10 per share.  The Series A and the short-term Series B warrants will have an exercise price of $3.85 per share and will be exercisable immediately upon issuance.  The closing of the offering is expected to occur on or about September 30, 2024. Gross proceeds are expected to be ~$5M. Net proceeds from the offering for working capital and other general corporate purposes. The stock price dropped 19% on Thursday during after market hours of trading.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"KTTA":"Pasithea Therapeutics Corp.","BK4139":"生物科技"},"translate_title":"Pasithea Therapeutics因500万美元私募股价下跌19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KTTA":0.9},"content_text":"Clinical-stage biotechnology company Pasithea Therapeutics (NASDAQ:KTTA) entered into definitive agreements for the issuance and sale of an aggregate of ~1.22M shares and warrants at a purchase price of $4.10 per share.  The Series A and the short-term Series B warrants will have an exercise price of $3.85 per share and will be exercisable immediately upon issuance.  The closing of the offering is expected to occur on or about September 30, 2024. Gross proceeds are expected to be ~$5M. Net proceeds from the offering for working capital and other general corporate purposes. The stock price dropped 19% on Thursday during after market hours of trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470677260"}